Manuscripts
Showing 1543 manuscripts.
Isoniazid pharmacokinetics, pharmacodynamics, and dosing in South African infants
Citation
David Z D'Argenio, Mark F Cotton, Raziya Bobat, George D McSherry, Shabir A Madhi, Vincent J Carey, Heiner I Seifart, Cedric J Werely, Courtney V Fletcher, Jennifer J Kiser, Rui Zhu. Isoniazid pharmacokinetics, pharmacodynamics, and dosing in South African infants. Therapeutic Drug Monitoring. 2012. 34: 446-451. PMID: 22695364Year
2012
Journal
Therapeutic Drug Monitoring
Study
P1041
Prevalence of congenital anomalies in infants with in utero exposure to antiretrovirals
Citation
Daniel G Muenz, Hans M L Spiegel, Daniel H Conway, Gwendolyn B Scott, Jeffrey T Talbot, David E Shapiro, Jennifer S Read, Katherine M Knapp, Susan B Brogly. Prevalence of congenital anomalies in infants with in utero exposure to antiretrovirals. Pediaric Infectious Disease Journal. 2012. 31: 164-170. PMID: 21983213Year
2012
Journal
Pediaric Infectious Disease Journal
Study
P1025
Extended prophylaxis with Nevirapine and Cotrimoxazole among HIV Exposed-Uninfected Infants is Safe
Citation
Extended prophylaxis with Nevirapine and Cotrimoxazole among HIV Exposed-Uninfected Infants is Safe. AIDS. 2012. 26: 325-33. PMID: 22112598Year
2012
Journal
AIDS
HIV disease severity and psychiatric symptomatology in perinatally HIV-infected youth.
Citation
HIV disease severity and psychiatric symptomatology in perinatally HIV-infected youth.. Archives of Pediatrics and Adolescent Medicine. 2012. 166: 528-35. PMID: 22312169Year
2012
Journal
Archives of Pediatrics and Adolescent Medicine
Study
P1055
Infant Outcomes After Maternal Antiretroviral Exposure in Resource-Limited Settings
Citation
Infant Outcomes After Maternal Antiretroviral Exposure in Resource-Limited Settings. Pediatrics. 2012. 129: e1525-e1532. PMID: 22585772Year
2012
Journal
Pediatrics
Study
P1054
Three Postpartum Antiretroviral Regimens to Prevent HIV Infection
Citation
Three Postpartum Antiretroviral Regimens to Prevent HIV Infection. New England Journal of Medicine. 2012. 366: 2368-79. PMID: 22716975Year
2012
Journal
New England Journal of Medicine
Study
P1043/HPTN 040
Safety and Immunogenicity of a Two-Dose Series of Quadrivalent Meningococcal Conjugate Vaccine in 2 to 10 Year-Old HIV-Infected Children
Citation
Safety and Immunogenicity of a Two-Dose Series of Quadrivalent Meningococcal Conjugate Vaccine in 2 to 10 Year-Old HIV-Infected Children. Pediaric Infectious Disease Journal. 2012. 31: 47-52. PMID: 21987006Year
2012
Journal
Pediaric Infectious Disease Journal
Study
P1065
Assessment of Developmental Changes in Infant Lopinavir Pharmacokinetics and its Impact on Weight Band Dosing
Citation
Assessment of Developmental Changes in Infant Lopinavir Pharmacokinetics and its Impact on Weight Band Dosing. Clinical Pharmacology & Therapeutics. 2012. 91: 243-249. PMID: 22190064Year
2012
Journal
Clinical Pharmacology & Therapeutics
Study
P1030
Laboratory Abnormalities Among HIV-Exposed, Uninfected Infants: IMPAACT Protocol P1025
Citation
Kunjal Patel, Marcia Mitchell, Gwendolyn B Scott, Jennifer S Read, Yanling Huo. Laboratory Abnormalities Among HIV-Exposed, Uninfected Infants: IMPAACT Protocol P1025. Journal of Pediatric Infectious Disease Society. 2012. 1: 92-102. PMID: 23687574Year
2012
Journal
Journal of Pediatric Infectious Disease Society
Study
P1025
Immunogenicity and Safety of 1 vs 2 Doses of Quadrivalent Meningococcal Conjugate Vaccine in Youth Infected with Human Immunodeficiency Virus
Citation
Immunogenicity and Safety of 1 vs 2 Doses of Quadrivalent Meningococcal Conjugate Vaccine in Youth Infected with Human Immunodeficiency Virus. Pediatrics. 2012. 161: 676-81. PMID: 22622049Year
2012
Journal
Pediatrics
Study
P1065